Circadian Clock and Beta Cell Stress Adaptation
Circadian Clock and Beta Cell Stress Adaptation
批准号:
8629855
负责人:
Vijay K Yechoor
金额:
$34.57万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-01 至 2019-01-31
关键词:
AblationAddressApoptoticBeta CellBiological PreservationCell physiologyCellsCellular StressCircadian RhythmsCouplingDataDiabetes MellitusDietDoseFailureFastingFunctional disorderGene TargetingGenesGeneticGlucoseGoalsHomeostasisHumanImpairmentInsulinInterventionKnockout MiceKnowledgeLeadLife StyleLigandsLightLinkMediatingMetabolicMetabolic syndromeModelingMolecularMolecular TargetMusNutrientObese MicePathogenesisPathway interactionsPeriodicityPeripheralPhasePhenocopyPhysiologicalPlasmaPreventionProcessProductionProteinsRegimenRegulationRoleSecondary toSignal TransductionStimulusStressStress TestsTamoxifenTestingTranscriptional RegulationUp-Regulationarmbiological adaptation to stresscircadian pacemakercombatdiabeticdiabetic patientendoplasmic reticulum stressfeedingin vivoinsightinsulin secretionisletloss of functionmitochondrial dysfunctionnovelpreventpublic health relevanceresearch studyresponseshift worksimulationtranscription factor
中文摘要
描述(由申请人提供):昼夜节律紊乱是现代生活方式的祸根,与糖尿病和代谢综合征密切相关。最近的人体研究也暗示b细胞功能障碍是代谢异常的重要组成部分。是的,
因此,必须了解生物钟和调节之间的相互作用?细胞功能的保护胰岛素分泌,以防止糖尿病。我们以前已经表明,通过删除小鼠中的非冗余核心时钟基因Bmal 1,生物钟的遗传破坏导致?细胞衰竭和糖尿病,继发于葡萄糖刺激的ATP产生受损、OXPHOS解偶联和葡萄糖刺激的胰岛素分泌受损(GSIS)。然而,无论是内在的?细胞钟是适应性应激反应所必需的。细胞未知。在初步研究中,我们证明了由轮班工作模拟诱导的中枢时钟中断,在诱导未折叠蛋白质反应(UPR)的过程中模仿了<$-细胞中Bmal 1的遗传中断,促凋亡基因CHOP的上调,提示<$-细胞中不可补救的ER应激,并且伴随着受损的GSIS。重要的是,在<$-细胞中缺失Bmal 1的小鼠由于<$-细胞衰竭而患糖尿病。令人惊讶的是,Rev-erb <$的缺失,时钟功能的负调控因子和Bmal 1靶基因,导致在<$-细胞中类似的未折叠蛋白反应(UPR)的诱导。我们还表明,ATF 4,一个关键的转录因子参与UPR,显示昼夜节律的表达,是Bmal 1的直接转录靶点。因此,我们假设内在的?-细胞时钟调节因子Bmal 1和Rev-erb?通过转录控制其关键成分来协调适应性UPR途径,以减轻ER应激。其广泛的目标是通过分子钟的遗传、环境和药理学调节来描绘ER应激诱导的细胞功能障碍中的关键昼夜节律钟调节途径。我们将具体1。B解剖中枢和外周时钟对ER应激和<$-细胞功能的不同作用,测试昼夜节律中断是否足以诱导ER应激和<$-细胞衰竭。我们还将确定细胞自主作用的分子时钟ER压力在<$-cells 2。确定Bmal 1和Rev-erb <$在UPR和ER应激中的转录靶点?-细胞和3。测试生物钟是否调节人类胰岛的ER应激适应性反应和胰岛素分泌反应。我们还将测试分子钟的药理学调节是否可以挽救糖尿病患者胰岛中的适应性应激信号。总的来说,拟议的研究将严格解决分子钟如何调节ER应激和细胞内稳态,并将导致对生物钟调节的适应性应激通路的新见解。我们设想,这项研究的结果将导致发现靶向疗法,以调节生物钟功能,从而在对抗糖尿病时保护细胞功能。
英文摘要
DESCRIPTION (provided by applicant): Circadian disruption, the bane of modern lifestyle, has been strongly associated with diabetes and metabolic syndrome. Recent human studies also implicate b-cell dysfunction as a significant component of the metabolic abnormalities. It is,
therefore, imperative to understand the interaction between the circadian clock and regulation of ?-cell function for the preservation of insulin secretion to prevent diabetes. We have shown previously that genetic disruption of the circadian clock, by deletion of Bmal1, a non-redundant core clock gene, in mice, leads to ?-cell failure and diabetes, secondary to impaired glucose-stimulated ATP production, uncoupling of OXPHOS and impaired glucose-stimulated insulin secretion (GSIS). However, whether the intrinsic ?-cell clock is required for adaptive stress responses in ?-cells is unknown. In preliminary studies, we demonstrate that central clock disruption induced by shift work simulation, phenocopies genetic disruption of Bmal1 in ¿-cells in inducing Unfolded Protein Response (UPR), upregulation of the pro-apoptotic gene CHOP, suggestive of irremediable ER stress in ¿-cells, and is accompanied by impaired GSIS. Importantly, mice with a deletion of Bmal1 in ¿-cells become diabetic due to ¿-cell failure. Surprisingly, deletion of Rev-erb¿, a negative regulator of clock function and a Bmal1 target gene, leads to similar induction of unfolded protein response (UPR) in ¿-cells. We also show that ATF4, a key transcription factor involved in UPR, displays circadian rhythmicity in expression and is a direct transcriptional target of Bmal1. We, hence, hypothesized that intrinsic ?-cell clock regulators, Bmal1 and Rev-erb¿, coordinate the adaptive UPR pathway, through transcriptional control of its key components, to mitigate ER stress. The broad goal is to delineate key circadian clock-regulated pathways in ER stress-induced ¿-cell dysfunction through genetic, environmental and pharmacological modulation of the molecular clock. We will specifically 1. Test if circadian disruption is sufficient to induce ER stress and ¿-cell failure b dissecting the differential role of the central and peripheral clocks on ER stress and ¿-cell function. We will also determine the cell-autonomous role of the molecular clock in ER stress in ¿-cells 2. Define the transcriptional targets of Bmal1 and Rev-erb¿ in UPR and ER stress in ?-cells and 3. Test if the circadian clock regulates ER stress adaptive responses and insulin secretory response in human islets. We will also test if pharmacological modulation of the molecular clock can rescue adaptive stress signaling in diabetic patient islets. Collectively, the proposed studies will critically address how the molecular clock regulates ER stress and ¿-cell homeostasis and will lead to novel insights into circadian clock regulated adaptive stress pathways in ¿-cells. We envision that the results from this study will lead to discovery of targeted therapies to modulate circadian clock function for the preservation of ¿-cell function in combating diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circadian disruption-induced mitochondrial dysfunction in diabetes
-
批准号:10317856
-
项目类别:
-
资助金额:$46.15万
-
财政年份:2021
-
负责人:Vijay K Yechoor
-
依托单位:
Circadian disruption-induced mitochondrial dysfunction in diabetes
-
批准号:10673967
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2021
-
负责人:Vijay K Yechoor
-
依托单位:
Tead1 - A Regulator of Quiescence and Proliferation in Pancreatic Beta Cells
-
批准号:10020885
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Vijay K Yechoor
-
依托单位:
Tead1 - A Regulator of Quiescence and Proliferation in Pancreatic Beta Cells
-
批准号:9032737
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Vijay K Yechoor
-
依托单位:
Tead1 - A Regulator of Quiescence and Proliferation in Pancreatic Beta Cells
-
批准号:9215521
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Vijay K Yechoor
-
依托单位:
Novel Regulators of Beta Cell Proliferation and Function
-
批准号:10257754
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Vijay K Yechoor
-
依托单位:
Novel Regulators of Beta Cell Proliferation and Function
-
批准号:10513301
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Vijay K Yechoor
-
依托单位:
Circadian Clock and Beta Cell Stress Adaptation
-
批准号:9010952
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2014
-
负责人:Vijay K Yechoor
-
依托单位:
Circadian Control of Islet Function
-
批准号:8073702
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2010
-
负责人:Vijay K Yechoor
-
依托单位:
Circadian Control of Islet Function
-
批准号:8101866
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2010
-
负责人:Vijay K Yechoor
-
依托单位:
Reversing Autoimmune Diabetes with Gene Therapy Induced Islet Neogenesis
-
批准号:7589346
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2009
-
负责人:Vijay K Yechoor
-
依托单位:
Reversing Autoimmune Diabetes with Gene Therapy Induced Islet Neogenesis
-
批准号:7745434
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2009
-
负责人:Vijay K Yechoor
-
依托单位:
Islet Neogenesis with Ngn3 Therapy Reverses Diabetes
-
批准号:7082026
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2004
-
负责人:Vijay K Yechoor
-
依托单位:
Islet Neogenesis with Ngn3 Therapy Reverses Diabetes
-
批准号:6912640
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2004
-
负责人:Vijay K Yechoor
-
依托单位:
Islet Neogenesis with Ngn3 Therapy Reverses Diabetes
-
批准号:7430363
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2004
-
负责人:Vijay K Yechoor
-
依托单位:
Islet Neogenesis with Ngn3 Therapy Reverses Diabetes
-
批准号:6816569
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2004
-
负责人:Vijay K Yechoor
-
依托单位:
Islet Neogenesis with Ngn3 Therapy Reverses Diabetes
-
批准号:7249476
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2004
-
负责人:Vijay K Yechoor
-
依托单位:
海外基金